PHASE-I AND PHARMACOKINETIC STUDY OF TIAZOFURIN (TCAR, NSC-286193) ADMINISTERED BY CONTINUOUS INFUSION

被引：0
|
作者：
BATIST, G
KLECKER, RW
JAYARAM, HN
JENKINS, JF
GRYGIEL, J
IHDE, DC
EDDY, JL
FINE, RL
KERR, IG
COLLINS, JM
机构：
[1] NCI,NAVY BRANCH,BETHESDA,MD 20205
[2] NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,MED CHEM & PHARMACOL LAB,BETHESDA,MD 20205
来源：
INVESTIGATIONAL NEW DRUGS | 1985年 / 3卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：349 / 355
页数：7
相关论文
共 50 条
  • [1] PHASE-I AND PHARMACOKINETIC STUDY OF TIAZOFURIN (NSC-286193) ADMINISTERED BY 5-DAY CONTINUOUS INFUSION
    RAGHAVAN, D
    BISHOP, J
    SAMPSON, D
    GRYGIEL, J
    WOODS, R
    COATES, A
    FOX, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 16 (02) : 160 - 164
  • [2] PHASE-I AND PHARMACOKINETIC STUDY OF TIAZOFURIN (NSC-286193)
    RAGHAVAN, D
    BISHOP, J
    LEVI, J
    FOX, R
    HEDLEY, D
    WOODS, R
    COX, K
    COATES, A
    TATTERSALL, M
    HILLCOAT, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 167 - 167
  • [3] PEDIATRIC PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF TIAZOFURIN (NSC 286193)
    BALIS, FM
    LANGE, BJ
    PACKER, RJ
    HOLCENBERG, JS
    ETTINGER, LJ
    SALLAN, SE
    HEIDEMAN, RL
    ZIMM, S
    SMITHSON, WA
    COGLIANOSHUTTA, NA
    REAMAN, GH
    POPLACK, DG
    CANCER RESEARCH, 1985, 45 (10) : 5169 - 5172
  • [4] PHASE-I STUDY OF TIAZOFURIN (2-BETA-D-RIBOFURANOSYLTHIAZOLE-4-CARBOXAMIDE, NSC-286193)
    ROBERTS, JD
    ACKERLY, CA
    NEWMAN, RA
    KRAKOFF, IH
    STEWART, JA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 166 - 166
  • [5] PHASE-I STUDY OF TIAZOFURIN (2-BETA-D-RIBOFURANOSYLTHIAZOLE-4-CARBOXAMIDE, NSC-286193)
    MAROUN, JA
    STEWART, DJ
    INVESTIGATIONAL NEW DRUGS, 1990, 8 : S33 - S39
  • [6] PHASE-I EVALUATION AND PHARMACOKINETICS OF TIAZOFURIN (2-BETA-D-RIBOFURANOSYLTHIAZOLE-4-CARBOXAMIDE, NSC-286193)
    MELINK, TJ
    VONHOFF, DD
    KUHN, JG
    HERSH, MR
    STERNSON, LA
    PATTON, TF
    SIEGLER, R
    BOLDT, DH
    CLARK, GM
    CANCER RESEARCH, 1985, 45 (06) : 2859 - 2865
  • [7] PHASE-I TRIAL AND PHARMACOKINETICS OF TIAZOFURAN (NSC286193) ADMINISTERED AS A 5-DAY CONTINUOUS INFUSION
    TRUMP, DL
    TUTSCH, KD
    KOELLER, JM
    RAMIREZ, G
    LOVE, RR
    TORMEY, DC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 344 - 344
  • [8] PHASE-II STUDY OF TIAZOFURIN (NSC-286193) IN THE TREATMENT OF ADVANCED SMALL CELL BRONCHOGENIC-CARCINOMA
    HOLOYE, PY
    CARR, DT
    DHINGRA, HM
    GLISSON, BS
    LEE, JS
    MURPHY, WK
    UMSAWASDI, T
    JEFFRIES, D
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (03) : 217 - 218
  • [9] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF HEXAMETHYLENE BISACETAMIDE (NSC-95580) ADMINISTERED AS A 5-DAY CONTINUOUS INFUSION
    EGORIN, MJ
    SIGMAN, LM
    VANECHO, DA
    FORREST, A
    WHITACRE, MY
    AISNER, J
    CANCER RESEARCH, 1987, 47 (02) : 617 - 623
  • [10] PHASE-I CLINICAL-STUDY WITH PHARMACOKINETIC ANALYSIS OF 2-BETA-D-RIBOFURANOSYLTHIAZOLE-4-CARBOXAMIDE (NSC 286193) ADMINISTERED AS A 5-DAY INFUSION
    TRUMP, DL
    TUTSCH, KD
    KOELLER, JM
    TORMEY, DC
    CANCER RESEARCH, 1985, 45 (06) : 2853 - 2858
12345